Literature DB >> 11349219

HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer.

A Ghaderi1, A Talei, B Gharesi-Fard, S H Farjadian, A Amirzargar, M Vasei.   

Abstract

Breast cancer is considered a major malignancy among women worldwide. The contribution of genetic elements to the onset of familial breast cancer has already been established. The current study investigate the alfele frequency of HLA-DRB 1 in 36 primary operable female breast cancer patients from southern Iran by polymerase chain reaction using sequence specific primers (PCR-SSP). Results were compared with those of 36 female control subjects. Statistical analysis was performed and P values were determined for each character. Our results indicated that the frequency of HLA-DRB 1*12 allele is significantly higher in the patient group (p<0.03) compared to the control group. In addition, HLA-DRB1*11 appeared to be as the most frequent allele in the control group (29.2%) and had approximately the same distribution among the patient group (22.5%).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349219     DOI: 10.1007/bf03032603

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  17 in total

1.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

Authors:  O Olerup; H Zetterquist
Journal:  Tissue Antigens       Date:  1992-05

2.  HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.

Authors:  M Feinmesser; A Sulkes; S Morgenstern; J Sulkes; S Stern; E Okon
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

3.  MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytes.

Authors:  T D Armstrong; V K Clements; S Ostrand-Rosenberg
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

4.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

5.  Serological and molecular study on the HLA phenotype of female breast cancer patients.

Authors:  C Casoli; P Zanelli; A Adorni; B R Starcich; T Neri
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

6.  HLA class II antigen expression in human papillomavirus-associated cervical cancer.

Authors:  S S Glew; M Duggan-Keen; T Cabrera; P L Stern
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

7.  CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion.

Authors:  R Dadmarz; M K Sgagias; S A Rosenberg; D J Schwartzentruber
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

Review 8.  Expression and susceptibility to modulation by interferons of HLA class I and II antigens on melanoma cells. Immunohistochemical analysis and clinical relevance.

Authors:  D J Ruiter; E B Bröcker; S Ferrone
Journal:  J Immunogenet       Date:  1986 Apr-Jun

9.  Changing trends. An overview of breast cancer incidence and mortality.

Authors:  L Garfinkel; C C Boring; C W Heath
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

10.  HLA expression in human hepatocellular carcinoma.

Authors:  A C Paterson; R Sciot; M C Kew; F Callea; G M Dusheiko; V J Desmet
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

View more
  9 in total

1.  HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia?

Authors:  Amal Baccar Harrath; Besma Yacoubi Loueslati; Wafa Troudi; Slama Hmida; Syrine Sedkaoui; Amel Dridi; Afef Jridi; Farhat Ben Ayed; Khaled Ben Rhomdhane; Amel Ben Ammar Elgaaied
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

2.  HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer.

Authors:  Majid Mahmoodi; Hedayat Nahvi; Mahdi Mahmoudi; Amir Kasaian; Mohammad-Ali Mohagheghi; Kouros Divsalar; Bijan Nahavandian; Abbas Jafari; Bita Ansarpour; Batoul Moradi; Asghar Aghamohammadi; Aliakbar Amirzargar
Journal:  Pathol Oncol Res       Date:  2011-07-01       Impact factor: 3.201

3.  HLA class-II allele frequencies in Turkish breast cancer patients.

Authors:  Faik Deniz Gun; Ozlem Goruroglu Ozturk; Ayse Polat; Gurbuz Polat
Journal:  Med Oncol       Date:  2011-03-04       Impact factor: 3.064

4.  Relationship between HLA-DRB1 gene polymorphism and breast cancer: A protocol for systematic review and meta-analysis.

Authors:  Linlin Liu; Xu Sun; Chenxi Yuan; Huaimin Liu
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

Review 5.  Genetic and molecular biology of breast cancer among Iranian patients.

Authors:  Meysam Moghbeli
Journal:  J Transl Med       Date:  2019-07-08       Impact factor: 5.531

6.  Association between DLA-DRB1.2 allelic diversity and development of mammary gland tumors in dogs.

Authors:  Seyed Milad Vahedi; Gholamreza Nikbakht; Shahram Jamshidi; Leila Lankarani; Nika Alimi; Atefeh Esmailnejad
Journal:  Acta Vet Scand       Date:  2019-11-14       Impact factor: 1.695

7.  Relevance of the MHC region for breast cancer susceptibility in Asians.

Authors:  Mikael Hartman; Jingmei Li; Peh Joo Ho; Alexis Jiaying Khng; Benita Kiat-Tee Tan; Ern Yu Tan; Su-Ming Tan; Veronique Kiak Mien Tan; Geok Hoon Lim; Kristan J Aronson; Tsun L Chan; Ji-Yeob Choi; Joe Dennis; Weang-Kee Ho; Ming-Feng Hou; Hidemi Ito; Motoki Iwasaki; Esther M John; Daehee Kang; Sung-Won Kim; Allison W Kurian; Ava Kwong; Artitaya Lophatananon; Keitaro Matsuo; Nur Aishah Mohd-Taib; Kenneth Muir; Rachel A Murphy; Sue K Park; Chen-Yang Shen; Xiao-Ou Shu; Soo Hwang Teo; Qin Wang; Taiki Yamaji; Wei Zheng; Manjeet K Bolla; Alison M Dunning; Douglas F Easton; Paul D P Pharoah
Journal:  Breast Cancer       Date:  2022-05-11       Impact factor: 3.307

8.  High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study.

Authors:  David Cantú de León; Delia Pérez-Montiel; Verónica Villavicencio; Alejandro García Carranca; Alejandro Mohar Betancourt; Victor Acuña-Alonzo; Alberto López-Tello; Gilberto Vargas-Alarcón; Rodrigo Barquera; Neng Yu; Edmond J Yunis; Julio Granados
Journal:  BMC Cancer       Date:  2009-02-05       Impact factor: 4.430

9.  HLA Class I Allele Frequencies in Southern Iranian Women with Breast Cancer.

Authors:  Mahboobeh Razmkhah; Abbas Ghaderi
Journal:  Iran J Basic Med Sci       Date:  2013-02       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.